The North America unit dose manufacturing market size is expected to reach USD 56.22 billion in 2030 and is projected to grow at a CAGR of 11.23% from 2025 to 2030. The rapidly growing pharmaceutical industry and rising demand for unit doses are factors driving the market.
Single-dose packaging has certainly become one of the most popular recent trends. The most obvious benefit is its ease of use and improved medication management, as they can be prescribed by the unit, ensuring that the person taking it does not exceed the prescribed dose. Stick packs are unique in the way that they can be used to package a variety of items, both dry and wet.
Measuring cups, teaspoons, tablespoons, and multi-dose containers for oral liquids and eye drops have been already seen. The current patient is seeking convenience. Doctors are also appreciating the importance of unit dose in prescription writing since it allows them to prescribe controlled substance oral liquid without concern of abuse as unit doses address the issue. It also enables pharmacists to store oral liquids in a secure manner, which is a significant additional benefit. Nearly every single unit dose oral solid or multiple-dose oral liquid could be transformed to a unit dose oral liquid due to this innovation.
However, owing to the COVID-19 pandemic's repercussions, the unit dose manufacturing market increased at a modest 11.0% year over year in 2020. By the end of 2020, the market started to recover. COVID-19-related illnesses are being treated using unit dosages. Hospitals have updated and implemented various new standard operating procedures to protect both patients and healthcare workers. As a consequence, it's crucial to consider out viral transmission by airborne transmission or direct contact. When unit dose medicines are used, some of the risks involved with handling and pouring doses from the same bottle are reduced.
This product will be delivered within 1-3 business days.
Single-dose packaging has certainly become one of the most popular recent trends. The most obvious benefit is its ease of use and improved medication management, as they can be prescribed by the unit, ensuring that the person taking it does not exceed the prescribed dose. Stick packs are unique in the way that they can be used to package a variety of items, both dry and wet.
Measuring cups, teaspoons, tablespoons, and multi-dose containers for oral liquids and eye drops have been already seen. The current patient is seeking convenience. Doctors are also appreciating the importance of unit dose in prescription writing since it allows them to prescribe controlled substance oral liquid without concern of abuse as unit doses address the issue. It also enables pharmacists to store oral liquids in a secure manner, which is a significant additional benefit. Nearly every single unit dose oral solid or multiple-dose oral liquid could be transformed to a unit dose oral liquid due to this innovation.
However, owing to the COVID-19 pandemic's repercussions, the unit dose manufacturing market increased at a modest 11.0% year over year in 2020. By the end of 2020, the market started to recover. COVID-19-related illnesses are being treated using unit dosages. Hospitals have updated and implemented various new standard operating procedures to protect both patients and healthcare workers. As a consequence, it's crucial to consider out viral transmission by airborne transmission or direct contact. When unit dose medicines are used, some of the risks involved with handling and pouring doses from the same bottle are reduced.
North America Unit Dose Manufacturing Market Report Highlights
- The outsourcing segment led the market with the largest revenue share of 60.13% in 2024. Unit doses lead to the minimization of credits for drugs coupled with greater control by a pharmacist over work patterns and schedules.
- The solid unit dose segment led the market with the largest revenue share of 49.71% in 2024. In 2018, oral solid dosage medicines accounted for 53% of all new pharmaceuticals approved by the FDA.
- The independent pharmacies segment led the market with the largest revenue share of 37.83% in 2024.
- The hospitals segment accounted for the second-largest revenue share in 2024. Unit dose packaging ensures precise dosing, reduces the possibility of medication errors, and supports medication safety protocols within hospital settings.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. North America Unit Dose Manufacturing Market Variables, Trends, & Scope
Chapter 4. North America Unit Dose Manufacturing Market: Sourcing Estimates & Trend Analysis
Chapter 5. North America Unit Dose Manufacturing Market: Product Estimates & Trend Analysis
Chapter 6. North America Unit Dose Manufacturing Market: End Use Estimates & Trend Analysis
Chapter 7. North America Unit Dose Manufacturing Market: Country Estimates & Trend Analysis, by Sourcing, by Product, By End Use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Catalent Inc.
- Unither Pharmaceuticals
- Thermo Fisher Scientific
- Corden Pharma
- Mikart LLC
- LTS LOHMANN Therapie-Systeme AG (TapeMark)
- Renaissance Lakewood LLC
- Medical Packaging Inc.
- American Health Packaging
- PCI Pharma Services
- Amcor PLC
- Bristol-Myers Squibb
- AbbVie Inc.
- Merck & Co. Inc.
- Pfizer Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | November 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 29.82 Billion |
| Forecasted Market Value ( USD | $ 56.22 Billion |
| Compound Annual Growth Rate | 11.2% |
| Regions Covered | North America |
| No. of Companies Mentioned | 15 |
